1. 1
Oxytocin Antagonist Affects Prepulse Inhibition in Prairie Voles
Crystal Vardakis a, Julia Palmer a, Karen L. Bales a*
a Department of Psychology, One Shields Ave. Davis, CA 95616 USA
cavardakis@ucdavis.edu a, jfpalmer@ucdavis.edu b, klbales@ucdavis.edu c
* Corresponding author at: Department of Psychology, One Shields Ave. Davis, CA 95616 USA
Tel.: +1 530 754 5890
E-mail address: klbales@ucdavis.edu (K.L. Bales).

2. 2
Abstract
There is evidence that impaired oxytocin (OT) biology is involved in the pathophysiology of
schizophrenia, in which patients also show deficits in sensorimotor gating. Percent prepulse
inhibition (% PPI) is a measure of sensorimotor gating often used in rodent studies, and is shown
to be modulated by OT. The goal of this study was to perform an initial, exploratory
investigation into the relationship between OT and PPI in prairie voles, a socially monogamous
rodent frequently used as an animal model of psychopathologies which involve social deficits.
Intranasal administration of OT is currently being proposed as a treatment for these
psychopathologies, including schizophrenia and autism. In this study, voles were divided into
groups which showed higher (>60%) or lower (<60%) levels of % PPI. Voles which had low %
PPI were administered intranasal OT and saline, while voles which had high % PPI were
administered a centrally acting OT receptor antagonist (central OTA or "COTA"), a peripherally
acting oxytocin antagonist ("POTA"), and saline via intraperitoneal injection. Both OTAs
decreased baseline startle amplitude in males, but not in females. Intranasal OT, compared to
saline, did not significantly improve % PPI. In males, COTA, compared to saline, significantly
worsened % PPI while POTA did not. For females, POTA worsened % PPI while COTA did not.
These results suggest that OT administered intranasally at this dose does not improve % PPI.
These results do however, support the involvement of the OT system in PPI and suggest that
there are sex differences in the role of OT in the startle response and in pre-pulse inhibition.
Key words: oxytocin,schizophrenia, autism, pre-pulse inhibition, startle

3. 3
1. Introduction
Oxytocin (OT) is a neuropeptide associated with attachment, parenting, and social
cognition in both humans and animals. The prairie vole (Microtus ochrogaster) forms pair-
bonds, exhibits biparental care, and also demonstrates a different distribution of OT and
vasopressin (AVP) V1a receptors in the brain than closely related polygynous species [1-5]. The
socioemotional bonding displayed by the prairie vole makes this species an excellent tool for
studying the neurobiological underpinnings of both healthy and disrupted social processing [6,
7]. However, very little data are available on sensorimotor gating in this species [8].
There is evidence that disruptions in OT biology may contribute to the pathophysiology
of schizophrenia [9-11] and autism [12-15]. The role of endogenous OT in schizophrenia,
however, is not well understood. For instance, in both male and female patients there appears to
be an association between peripheral OT and symptom severity. Rubin and colleagues
discovered that although OT levels remain fairly constant in males and females over time (42
days) and higher peripheral OT levels predict less severe symptoms, these manifest differently in
each sex. For instance, female patients with schizophrenia who have higher peripheral OT levels
experience significantly reduced delusions, hallucinations, paranoia, passive social withdrawal,
and tension, and tend not to demonstrate as much blunted affect, emotional withdrawal, and
depression. There were trends in male patients for an association between higher peripheral OT
levels and lower social avoidance and aggression. Male and female patients with higher
peripheral OT levels have significantly better prosocial scores on the Positive and Negative
Symptom Syndrome Scale (PANSS) [16].
Recent studies have shown that exogenous OT administration reduces some of the social
deficits observed in schizophrenia [17] and autism [18, 19]. In patients with schizophrenia,
intranasal OT significantly improved the ability to accurately identify the intentions of

4. 4
individuals during a gift-giving interaction, and significantly reduced patients' positive symptoms
and overall PANSS score compared to placebo [20]. In 2010, Feifel and colleagues found that
chronic intranasal OT treatment given adjunctively with schizophrenic patients' current
antipsychotic medication significantly improved patients' total PANSS, positive symptoms, and
clinical global impressions severity (CGI-S), which measures illness severity, rate of total
improvement, and the therapeutic effect of drug treatment [21]. In a follow up study, Feifel and
colleagues further demonstrated that intranasal OT administration significantly improved
patients' total recall and performance in other cognitive and working memory tasks, as compared
to placebo [22]. In patients with autism, intranasal OT administration improved facial affect
recognition [23] and intravenous (i.v.) OT administration reduced repetitive behaviors [24] and
improved patients' ability to recognize emotion in spoken phrases [25].
Sensorimotor gating is a cognitive process that enables us to filter out irrelevant stimuli
from the constant flow of sensory and cognitive input. Deficits in sensorimotor gating are present
in patients with schizophrenia [26-30], autism [31], bipolar disorder [32, 33], obsessive
compulsive disorder (OCD) [34], attention deficit hyperactivity disorder (ADHD) [35], and are
also common in patient groups that display tic-like behavior [36, 37]. These disorders, especially
schizophrenia and autism, are associated with impairments in social processing, cognition, and
behavior, thus limiting multiple patient populations from forming typical social relationships.
Sensorimotor gating can be measured in rodents by testing prepulse inhibition (PPI) in a
sensory startle test. PPI is the suppression of the response to a startle-eliciting stimulus (such as
a loud noise or puff of air) when it is closely preceded by a less intense stimulus (such as a less
intense sound), known as the prepulse. The % PPI is the proportion of the startle response that
the subject is able to inhibit. A lower %PPI is therefore considered a worsening of sensorimotor
gating, while a higher %PPI is considered an improvement. Previous rodent studies indicate that

5. 5
OT may modulate the expression of PPI. In one study, dose-dependent OT blocked amphetamine
and dizocilpine induced deficits in PPI [38], suggesting that OT is associated with protecting
neuronal functioning in the sensorimotor gating circuit. Furthermore, PPI in Brown Norway
(BN) rats, which is regularly poor, improved after central OT administration [39]. Finally,
phencyclidine (PCP)-induced impairment of PPI was worse in OT knockout mice (compared to
wild type mice), suggesting that endogenous OT may play a role in ameliorating the PCP
induced impairment of PPI [40].
Links between deficits in social behavior and sensorimotor gating have been shown in both
disorders of cell-cell communication and in behavioral models, such as social isolation rearing.
Enzymes belonging to the Phospholipase C family (PLCs) are critical in the signal transduction
pathways of cells. PLCs are best known for their role in cleaving phosphatidylinositol 4,5,-
bisphosphate (PIP2) into diacyl glycerol (DAG) and inositol 1,4,5-triphosphate (IP3) in G
protein-coupled receptors. Disruptions in PLC signaling pathways are known to have detrimental
effects on normal social behavior and sensorimotor gating. PLC β1 KO mice showed clear PPI
deficits compared to wild type mice [41]. Socially, both sexes of PLC β1 KO mice had reduced
social behavior compared to wild type mice showing less social interaction, whisker trimming,
social dominance, and nest building. The Wnt pathway of nearly all eukaryotic organisms is a
signaling pathway involved in cell fate determination. When the Wnt protein binds to a specific
G protein-coupled receptor, the signal is sent to the Dishevelled (Dsh) protein which consists of
three conserved protein domains, one being the PDZ domain, the signal can branch off into
several different pathways. Dvl1 is a gene that codes for a Dsh that regulates cell proliferation
and neuroblast specifications. Similar to PLC β1 KO mice, Dvl1 KO mice showed deficits in
social behavior and sensorimotor gating [42]. Whisker trimming, barbering, grooming, sniffing,
and nesting behavior were all reduced in Dvl1 KO mice. In male Hooded Lister rats, social

6. 6
isolation rearing significantly worsened PPI at all inter stimulus intervals (the pause in between
pulses) compared to socially reared rats [43].
The dopamine system was important in restoration of PPI in both the above described cell-
cell communication models and in social isolation models [44]. For instance, PPI was restored in
PLC β1 KO mice at all prepulse levels after administration of the dopamine (D2) receptor
antagonist haloperidol [41]. In male Sprague-Dawley (SD) rats, the dopamine antagonists
seroquel [45], olanzapine [43, 45], raclopride [46], and clozapine [47] reversed the deficits in PPI
caused by social isolation rearing. Further, social isolation significantly reduced postsynaptic D2
receptor expression in the prelimbic area of the PFC, as well as worsening PPI compared to
socially reared rats [48]. In a study comparing rat strains, SD and Fischer rats, but not Lewis rats,
reared in isolation showed deficits in PPI [49] and when treated with apomorphine, a
nonselective dopamine agonist, PPI was disrupted only in healthy Fischer rats. Dopamine
agonists consistently worsen PPI in several different rodent strains [50] while dopamine
antagonists generally improve PPI, depending on the antagonist and rodent strain. This has been
demonstrated by a worsening of PPI through the administration of drugs that increase dopamine
release,with PPI restoration following administration of dopamine antagonists [51, 52].
OT has been shown to have "protective" effects against many DA agonists such as cocaine
[53, 54], amphetamine [55], and apomorphine [56, 57]. The association between DA and OT in
sensorimotor gating is unknown but anatomical studies reveal that their neuronal fibers and
receptors are close neighbors in the CNS [58, 59] as both neurotransmitter systems are essential
for producing relevant behaviors. Extensive research has revealed the importance of DA and OT
in stimulating female and male sexual behavior, pair-bonding, and social bonding in studies of
rodents, primates, and humans [59]. Although the neuronal circuits for socioaffiliative behaviors
and sensorimotor gating are different, both behaviors are dependent on the nucleus accumbens

7. 7
(NA) which is heavily populated with OT and DA receptors, specifically D2 receptors. OT and
DA in the NA facilitate partner preference [60-62] and pairbonding [63-65] in prairie voles.
Despite its efficacy as a pharmacotherapy in the abovementioned studies, it is unclear whether
OT is actually crossing the blood-brain-barrier (BBB) when administered intranasally. AVP, a
closely related neuropeptide to OT, has been shown to cross the BBB in humans [66], but OT
itself has not. OT and AVP are of a similar size, but BBB penetrance depends on many
characteristics of peptide structure. It is therefore possible that the effects of intranasal OT in
human studies are due to peripheral feedback on the central nervous system, possibly via
receptors on the myelinated vagus [67-69]. It is notable that other modes of peripheral
administration such as iv in humans [24, 25] and subcutaneous injections in voles [70] have also
been shown to affect social functioning. However, for translational reasons we felt that it was
important to examine OT effects in the mode closest to that being used in humans. Recent work
in rodents has shown that intranasal OT crosses the BBB in rodents [71] and that acute intranasal
OT at this dose results in effects on social behavior similar both in direction and effect size to
those seen in humans [72].
PPI in prairie voles has been described in only one previous study [8]. However, prairie
voles are becoming an increasingly commonly used model for drug treatments on
psychopathology [72, 73]. This preliminary study was intended to expand our knowledge of the
relationship of OT to PPI in voles. We particularly wanted to test intranasal OT at a dose both
used in humans and shown to affect social behavior acutely in voles. Antagonists were also
included as an additional probe for involvement of the OT system. This is the first study to
investigate the effects of intranasally administered OT on PPI in rodents or tested the effects of
OT receptor antagonists (OTA). The inclusion of both an OTA that crosses the blood-brain
barrier ("central OTA" or "COTA") and one which does not ("peripheral OTA" or "POTA")

8. 8
allowed us to make some initial observations as to OT’s potential site of action. We
hypothesized that intranasal OT would improve PPI as compared to placebo, and that central and
peripheral OTAs would worsen PPI as compared to placebo, with COTA reducing PPI more than
POTA.
2. Materials and methods
2.1 Experimental animals
Male (n=89) and female (n=74) prairie voles were housed with a same sex cage-mate at weaning
in standard rodent shoebox cages (27 cm x 16 cm x 13 cm) in separate rooms by sex. Animals
were housed on a 14:10-hr light-dark cycle and received food (Purina High-Fiber Rabbit chow)
and water ad libitum. Subjects were ear-clipped at least a week before initial testing. Initial
startle testing occurred between 50-60 days of age and subjects were tested a second and third
time with 7-10 days spaced between each test day. Only two males and two females from the
same litter were eligible for initial testing in order to reduce genetic bias. If neither sibling
(within each sex) demonstrated sufficient %PPI according to our cutoff detailed below, then only
one sibling was used as a subject. However, if both siblings showed sufficient %PPI, then both
were included as subjects. See Figure 1 for study design.
2.2 Startle equipment
Two SR-LAB startle boxes (San Diego Instruments, San Diego, California, USA) were used to
test PPI, with one animal per startle box. Both startle boxes contained a ventilated Plexiglas
cylinder startle chamber (8.2 cm in diameter) mounted on a Plexiglas base (12.5 x 25.5 cm). A
speaker mounted 24 cm above the animal produced the prepulse stimuli (74, 78, 82, 86, 90 dB),

9. 9
startle stimuli (120 dB), and background noise (70 dB). A piezoelectric accelerometer
underneath the base detected the animal's motion.
2.3 Startle test
Subjects underwent an initial acoustic startle test to determine PPI. Each test began with a 5
minute acclimation period with no acoustic stimuli. The acoustic startle test consisted of 7
sessions of 7 trials, where trials included five different prepulse volumes (74 dB, 78 dB, 82 dB,
86 dB, 90 dB) plus the startle; a trial containing the startle stimulus only (i.e. baseline startle);
and a trial which was a baseline reading of the animals' movement with no prepulse or startle
stimuli. These trials were presented in a pseudorandom fashion to each animal. The test
consisted of the following: prepulse for 20 ms, background noise for 80 ms, the startle stimulus
for 40 ms, background noise for 25 ms, and then no stimuli for 15 s until the next trial. % PPI
was calculated by the following formula: [1-( startle amplitude following prepulse-startle
pair/startle amplitude following startle-only)] × 100 [74]. Thus, a higher score on this measure
means more inhibition of the startle response.
We initially sorted animals into two groups dependent on response to the pre-test, using a
rough estimate of + 60% prepulse inhibition of startle. This cutoff was intended not to have any
special meaning but primarily to create two groups, one of which started with low inhibition (and
thus had room to improve when given OT); and one which started with high inhibition (and thus
had room to get worse when given an OTA). Average % PPI for the voles put into the intranasal
OT experiment was 16.08 + 9.85% at the 90dB prepulse level, while average % PPI for voles put
into the OTA experiment was 67.63 + 1.97% at the 90dB prepulse level.

10. 10
Because prairie voles generally inhibit their startle response most successfully at the loudest
prepulse tone (Bales and Palmer, unpublished data), the average score from the loudest prepulse
(90 dB) was emphasized both in the selection process and in the following analyses.
2.4 Treatments
2.4.1 Intranasal OT treatment
Animals that showed less than 60% prepulse inhibition in the initial startle test were put into the
OT study, which investigated whether intranasal OT could improve PPI. Animals (n=24)
received 25 µl of intranasal OT (0.8 IU/kg, Bachem, Torrance, CA) or saline (0.9 NaCl, Baxter,
Deerfield, IL); each animal received both treatments, one week apart. The treatments were
administered with a cannula needle attached via cannula tubing to a 23-gauge needle on a
Hamilton syringe. Treatments were administered in small droplets, alternating between nostrils.
The cannula needle did not touch the animal's nose – it was held in front of the nostril so the
animal would inhale the droplets. Saline and OT treatments were prepared prior to testing and
stored at -20°C in individual 0.6 ml microtubes. Treatment administration was randomized such
that half of the males (6 out of 12) and half of the females (6 out of 12) received intranasal OT
on their first day of treatment (second startle testing day) and the other half of the males and
females received intranasal saline. Startle testing began 15 minutes after intranasal treatments.
When administered intranasally in humans, OT has prosocial effects and is well tolerated [75].
Furthermore, our lab has found that intranasal OT administration to prairie voles is sufficient to
produce behavioral changes, similar to those seen in human studies, 15 minutes later [72].
Because the pharmacokinetics of intranasal OT are not available for prairie voles, this
therapeutic effect was used as a proxy in order to determine a reasonable dose.

11. 11
2.4.2 Intraperitoneal OTA Treatment
Animals that demonstrated over 60% PPI in the initial startle test were put into the OTA study,
which investigated whether OTA would reduce PPI. Animals (n=40, 20 males and 20 females)
received two 50 µl intraperitoneal (ip) injections. One group received either an OT receptor
antagonist with limited ability to cross the blood-brain barrier (BBB) (‘POTA’, 1 mg/kg ip,
Bachem, Torrance, CA) or saline; while the other group received either an antagonist which does
cross the BBB (‘COTA’, 1 mg/kg ip, Santa Cruz Biotechnology, Inc, Santa Cruz, CA) or saline.
Order of administration was counter-balanced. Testing began one hour post-injection for both
antagonists, based on previous studies cited below.
The POTA used, d(CH2)5[Tyr(Me2)]OVT, is an OT antagonist [76] which has been widely
used in behavioral studies in prairie voles both centrally [77] and peripherally [70, 78-80] at the
same dosage used here. This antagonist has also been shown to affect feeding behavior [81] in
rats when given peripherally, and both feeding [82] and sexual behavior [83] when given
centrally. Its molecular weight is listed as 1075.32 g/mol (Bachem, Torrance, CA), which is far
outside of the ideal range for compounds to pass through the BBB (molecular weights less than
500) [84]. However, this molecular weight is similar to that of OT (1007.2 g/mol) which crosses
the BBB only at very small percentages (1.3%) in adult rodents [85]. Please note that prairie
vole OT receptors display 92% homology with rat receptors (BLAST; accession numbers
DP001214.1 for vole OT receptor and NM_012871.2 for rat OT receptor).
The COTA used, L-368,899, is of a much lower molecular weight (554.26 g/mol) and can
penetrate the BBB in rodents [86]. It has been shown to enter the CSF and to accumulate in
limbic areas [87] in monkeys, and to affect interest in infants, sexual behavior [87] and behavior
towards pair-mates in marmoset monkeys [88], and is well-tolerated in rats and dogs [89]. For
this study, we chose the lower dosage given in [87]. While the COTA will obviously act also on

12. 12
peripheral receptors, its penetration to the central nervous system will be much higher. Although
initial doses for the two OTAs used in this project were the same, they were chosen based on
previous behavioral effects, and not intended to be at identical molar concentrations but rather to
use as a starting point for investigation of the role of the OT system in PPI.
All injections were carried out with 26-gauge needles on a Hamilton syringe. COTA and
POTA were mixed a week prior to treatments and stored at -20°C in individual 2 ml micro
centrifuge tubes. Treatment administration was also randomized. Startle testing began one hour
after ip injections based on other studies in which behavioral changes are observed one hour post
ip injection [70, 87].
2.5 Data analysis
2.5.1 Analysis of baseline and drug-tested startle amplitude
The maximum startle amplitude from the two experiments was analyzed for effects of
treatment, sex, and a treatment by sex interaction. The data of all pulse alone trials (no prepulse)
were averaged for each animal. Because animals were tested more than once, the identity of the
animal (Animal ID) was used as a random factor in the model. This prevented pseudoreplication
of results and accounted for the variability due to individual differences.
2.5.2 Analysis of % PPI
In order to simplify our models, we first checked for trial by treatment and sex by treatment
interactions. There was a significant trial by treatment interaction for the animals in the
intranasal OT experiment (F9,198 = 3.37, p = 0.0007), as well for as the animals in the OTA
experiment (F12,344 = 8.76, p < 0.0001). In the OTA experiment, there was also a trend for a sex
by treatment interaction (F2,344 = 2.78, p = 0.0631). Data were therefore analyzed separately for

13. 13
each trial, and in the OTA experiment, also analyzed separately by sex. Results for both
experiments were analyzed by mixed model ANOVA, with treatment and week as fixed effects
and animal ID as a random effect (and in the OT experiment, sex was a factor in the model as
well). Because voles display quite poor prepulse inhibition at lower prepulses, the trial with the
90 dB prepulse was viewed as the most informative trial. Residuals were checked for normality
and when necessary, transformed. Post-hoc tests were calculated using least-squares means. All
tests were two-tailed and significance was set at p < 0.05.
Because individual differences in a repeated measures design can be swamped in a standard
graph of means + standard errors, and indeed can often make significant differences look non-
significant and vice versa, the bottom panel of each graph in Figures 2-5 indicates the means +
standard errors of the difference for each individual between saline and the other treatment (OT,
COTA, POTA).
3. Results
3.1 Baseline Startle
In the intranasal OT experiment, baseline startle showed a trend for an effect of treatment (F1, 21
= 3.87, p = 0.062; Figure 2), with OT tending to result in lower baseline startle, but no significant
effect of sex or sex by treatment interaction. There was also a significant effect of animal ID
(F21, 21 = 10.78, p < 0.0001).
In the OTA experiment, baseline startle showed a significant effect of treatment (F1, 36 = 3.75, p
= 0.033; Figure 3); there was no effect of sex (F1,36 = 0.02, p = 0.892), but a moderately
significant sex by treatment interaction (F2,36 = 3.23, p = 0.051). Post-hoc tests in males showed

14. 14
significant differences between saline and COTA (t1 = 2.605, p = 0.013) and between saline and
POTA (t1 = 2.177, p = 0.036). There was also a significant effect of animal ID (F38,36 = 6.84, p
<0.0001).
3.2 Effects of intranasal OT administration on % PPI
For 90 dB trials, treatment had no significant effect on PPI (F1,20 = 0.49, P = 0.491; Figure 4),
nor were there any other significant predictor terms in the model. No predictor terms were
significant for trials 4, 3, or 1. However, in 78 dB trials there was a significant effect of
treatment, such that intranasal OT administration significantly worsened PPI in both sexes (F1,20
= 5.81, P = 0.026), and a trend for animal ID (F21,20 = 1.98, P = 0.066).
3.3 Effects of intraperitoneal OTA administration on % PPI
For 90 dB trials, there was a significant effect of treatment (F2,35= 3.31, P = 0.048), with OTA
treatment disrupting PPI (Figure 5). Post-hoc tests (least-squares means) indicated that for
males, COTA significantly worsened PPI as compared to saline treatment (t = 2.57, p = 0.015),
while POTA did not (t = 0.14, P = 0.892). For females, POTA worsened PPI as compared to
saline (t = 2.11, P = 0.042), while COTA did not (t = .295, P = 0.770). Animal ID was also
significant (F38,35 = 1.94, P = 0.012).

15. 15
For 86 dB trials, there were no significant terms in the model. For 82 dB trials, there was a
significant effect of animal ID (F39,35 = 2.61, P = 0.002). There were no significant effects in 78
or 74 dB trials.
4. Discussion
This study adds to a growing literature on the role of OT receptor functioning in
sensorimotor gating. Both a centrally acting OTA (COTA), and an OTA with limited BBB
penetrance (POTA), reduced startle amplitude in males but not in females. COTA worsened PPI
significantly in males in response to a 90 dB prepulse, while females responded with worsened
PPI to the POTA. This was partially different from our expectation, that COTA would reduce
PPI more than POTA in all subjects, regardless of sex. Intranasal treatment, on the other hand,
had no effects on PPI except at 78 dB trials, in which it impaired PPI in both sexes.
Our study identified potential sex differences in how PPI is affected by the OT system in
prairie voles. Both male and female prairie voles have a high density of OT receptors in the NA
shell and core [90]. These regions of high OT receptor concentrations facilitate pair-bonding
behavior and parental care in prairie voles [91-93]. OT receptors are also present in the brain
stem and spinal cord [94, 95], areas that are heavily associated with auditory processing and
movement. The hypothesized PPI pathway in rodents includes the NA which serves as a key
relay station within the sensorimotor gating circuit [96-98]. Peripherally administered OTA (and
indeed, intranasally administered OT) may have affected baseline startle amplitude and PPI via
feedback from OT receptors in the autonomic nervous system. In prairie voles, OT has been
shown to affect heart rate variability [99], and to attenuate the autonomic response to a social
[99] or environmental [100] stressor. One possibility is that the OTAs were acting via the

16. 16
myelinated vagus [69]; intranasal OT itself might also act via the trigeminal nerve [101] which
projects to the brainstem.
The Acoustic Startle Response (ASR) pathway consists of excitatory connections from
the cochlea, to the cochlear root nucleus (CRN), to the nucleus reticularis pontine caudalis
(NRPC), and then to the motor neurons (MN) in the spine. Within this pathway, PPI occurs
starting with excitation from the CRN and dorsal cochlear nucleus to the inferior colliculus (IC),
continues with excitation to the superior colliculus (SC) then to the pontine tegmental nucleus
(PTN), and ends with inhibition at the NRPC [102]. The limbic cortex (temporal cortex and
medial prefrontal cortex), hippocampus (HPC), ventral striatum (which includes the NA), ventral
pallidum (VP), and the pontine tegmentum constitute the "higher" network (the "limbic cortico-
striato-pallido-pontine circuit"), helping to regulate PPI and meet with the ASR circuit at the
NRPC [102].
There is a large amount of evidence that glutamate (GLU), the most abundant
neurotransmitter in the vertebrate nervous system, is also involved in PPI. In male SD rats, PPI
was significantly worsened in social isolation reared rats after administration of the non-
competitive NMDA receptor antagonist dizocilpine (MK-80) with the highest dose disrupting
PPI even in control rats [103]. Further, pretreatment of the antipsychotics haloperidol and
clozapine failed to restore PPI after MK-80 administration [104] suggesting that perhaps DA
antagonism is not sufficient in restoring NMDA (GLU) antagonism. In another study, male SD
rats treated with MK-80 were given either the D1 agonist SKF 38393 or the D2 agonist
quinpirole to investigate the relationship between GLU and DA [105]. Treatment with SKF
38393 and dizocilpine, but not SKF 38393 or dizocilpine alone, was sufficient in disrupting PPI.
However, dizocilpine and quinpirole had no effect on PPI. Clozapine and haloperidol were
unsuccessful in restoring PPI in animals treated with dizocilpine and SKF 38393 but the D1

17. 17
antagonist SCH 23390 significantly improved PPI. These results suggest that D1 receptors
support PPI if the NMDA glutamatergic system fails. GLU acts on ionotropic (NMDA, Kainate,
AMPA) and metabotropic (mGLu) receptors, as this difference in receptor type has functional
relevance. In DBA/2J mice, only mGlu1 receptor antagonists were able to improve PPI while
mGlu2/3, mGlu5, mGlu7, and mGlu8 antagonists had no effect [106]. Although not all mGluR
affected PPI in this study, Zou and colleagues showed that mGlu5 is involved in PPI [107].
Less is known about how central GLU and OT are associated in PPI but there is some
evidence that these systems are connected in methamphetamine administration studies. For
instance, OT inhibited the methamphetamine induced conditioned place preference in male
Swiss mice and prevented an increase in extracellular GLU in the MPFC after an
immobilization-induced stress test [108]. In a later study, OT reduced the increased expression of
NMDA receptor subunit NR1 in the PFC while increasing the expression of the GLU transporter
GLT1 in the hippocampus after methamphetamine administration [109]. Clearly OT and OTA
effects may interact with GLU and DA in order to affect startle amplitude and PPI.
Since OT receptor binding potential in the NA and other areas of the proposed PPI
pathway does not differ between male and female virgin voles [91, 93], the sex difference we
found in PPI response to the central and peripheral OTAs likely results from a mechanism other
than sex differences in central receptor binding. It is notable that male and female prairie voles
have been found to respond differently to peripherally administered OT in other contexts [70].
Previous studies of rodents have demonstrated sex differences in PPI, though the evidence is
conflicting. For instance, in Wistar rats ASR and PPI were significantly greater in males than in
females with prepulse intensities of 76, 80, and 84 dB but not 72 dB [110]. This finding is
somewhat consistent with human research in that healthy human males display greater PPI than
healthy females but at lower prepulse intensities [111]. Similarly in CBA/CaJ mice, males

18. 18
showed significantly greater ASR and PPI compared to pre- but not post-menopausal female
mice [112]. Since % PPI is a calculated percentage of ASR reduction, the relationship between
ASR and PPI should be inversely proportional with PPI lower when ASR is greater. However, in
both these studies, this relationship was not observed.
In one study investigating the effects of estrous cycle on PPI, female SD rats showed
worsened PPI compared to males when they were in the proestrus phase of the estrous cycle, but
not when they were in the estrous or diestrus phase [113]. However, other studies have found
that the estrous cycle does not affect PPI in either Sprague-Dawley rats or in the inbred mice
strains C57BL/6J (C57) and C3H [114, 115]. Humans also show sex differences in PPI which
vary according to the menstrual cycle [116]. For instance, in the midluteal phase, when estrogen
and progesterone are highest, healthy women show the greatest reductions in PPI compared to
when they are in the follicular phase [117].
Sex differences in humans also exist with respect to the occurrence and severity of
schizophrenia. Specifically, schizophrenia is more prevalent and deleterious in males than in
females [118], and there is evidence that menstrual cycle affects the course of the disorder.
Although plasma OT levels do not change during the menstrual cycle in women with
schizophrenia, social cognition and overall psychopathology vary during different phases of the
cycle [119, 120]. It is possible that estrogen is primarily responsible for this variation since both
the genes for OT and OT receptors are estrogen responsive [121, 122].
The fact that intranasal OT had no significant effect on improving PPI, and even
significantly worsened PPI at 78 dB, was unexpected based on previous studies [123], especially
when considering that the circuits involved in social behavior and those involved in PPI share
some common areas. It is notable that OT at this dosage also tended to reduce baseline startle
amplitude. One possible explanation for this unforeseen result is that the intranasal OT dosages

19. 19
which acutely increase pro-social behavior in prairie voles [124] differ from those necessary to
alter PPI. A complete dose-response study of intranasal OT would help distinguish which
dosages are optimal for improving social behavior and PPI, and the extent to which they differ.
This could then become an important treatment consideration when translating to human
subjects. In addition to dosage, our chosen route of OT administration and/or the time period in
between OT treatment and startle testing could have been misguided which might explain why
PPI was unaffected after intranasal OT treatment. In the two studies looking at OT and PPI in
rats, OT was administered subcutaneously and startle testing began 30 min after OT treatment
[123]. However, startle testing began 10 min after subcutaneous OT administration when it was
quickly followed by subcutaneous amphetamine, apomorphine, and MK-801 administration [55]
which suggests that peripheral OT may influence startle testing more than central OT. If we had
included a test group that received peripheral OT with known working dosages [125, 126], then
we could compare PPI from the intranasal and peripheral OT groups. Another test group we
could have included is a group that received a DA antagonist for positive control. In all of the
existing literature the authors included application of drugs manipulating the DA system and so it
may have been wise to apply DA antagonists to the poorly inhibiting voles and see if this
principle holds true...
Another potential reason why OT did not significantly improve PPI might be due to
differences between inbred versus out-bred rodents. OT administered subcutaneously to male
Sprague-Dawley (SD) rats, which are out-bred, had no significant effect on PPI from baseline.
However, in Brown Norway (BN) rats, which are in-bred, increases in the dose of subcutaneous
OT injections were directly related to increases in % PPI of the startle response [123]. The
prairie voles used in our study were out-bred and it is possible that inbred strains have linked
genes associated with OT receptor morphology in the PPI circuitry. Previous reports on PPI and

20. 20
antipsychotics in rodent studies indicate that there are differences in drug effectiveness based on
inbred and out-bred strains [127-129]. In this case, we might expect an out-bred rodent species to
be the best translational model for humans. The prairie voles in our study showed considerable
individual differences, shown by the significance of the random factor “ID”, which could relate
to baseline differences in OT, DA, or GLU receptors, and which make an interesting topic for
further study.
There were several limitations of this study, which was intended to be preliminary in
many respects. For both OT and OTAs, we used only single dosages without dose-responses.
While this weight-adjusted dose of OT has been shown to cause similar acute changes in social
behavior in voles as it does in humans [72], the differing construction of the rodent nose and
differences in potential modes of administration (which can vary or be poorly described even in
many human studies) may also have affected the current findings [130]. In addition to more
doses, it would be useful to have combined agonist/antagonist treatments, as well as an
antipsychotic drug treatment as a positive control. Because this study uses a different species as
well as a different route for OT treatment, additional experiments are required to compare
directly to results from rat and mouse models.
In summary, we found that while intranasal OT had minimal or detrimental effects on
PPI at the dosage used to increase social contact in this species, male PPI responded to a
centrally acting OTA and female PPI to a peripherally acting OTA. Full dose-responses for both
OT and OTAs will be needed to confirm and extend these very preliminary results; however,
these results suggest that further investigation of the role of OT in the PPI circuit is warranted.
5. Acknowledgements

21. 21
This research was supported by National Institutes of Child Health and Human Development
grants 071998 and 060117, and the University of California, Davis. We would like to thank
Allison Perkeybile for general assistance, Benjamin Ragen and Sara Freeman for assistance in
editing of the manuscript, and Drs. Rhonda Oates-O’Brien and Cindy Clayton for veterinary
assistance and animal care.
References
[1] Olazabal,D.E., Young,L. J. Oxytocinreceptorsinthe nucleusaccumbensfacilitate "spontaneous"
maternal behaviorinadultfemaleprairie voles.Neuroscience.2006,141:559-68.
[2] Lim,M. M., Murphy,A. Z.,Young,L. J.Ventral striatopallidal oxytocinandvasopressinV1areceptors
inthe monogamousprairie vole(Microtusochrogaster).J.CompNeurol.2004,468:555-70.
[3] Ophir,A.G., Gessel,A.,Zheng,D.J.,Phelps,S.M.Oxytocinreceptordensity isassociatedwithmale
matingtactics andsocial monogamy.HormonesandBehavior.2012,61:445-53.
[4] Insel,T.R.,Shapiro,L. E. Oxytocinreceptordistributionreflectssocial organizationinmonogamous
and polygamousvoles.Proceedingsof the National Academyof Sciences.1992,89:5981-5.
[5] Carter,C. S.,Grippo,A. J.,Pournajafi-Nazarloo,H.,Ruscio,M.G., Porges,S.W. Oxytocin,vasopressin
and sociality.Prog.BrainRes.2008,170:331-6.
[6] Aragona,B. J.,Wang, Z. The prairie vole (Microtusochrogaster):ananimal model forbehavioral
neuroendocrine researchonpairbonding.ILARJ.2004,45:35-45.
[7] Kuehn,B.M. Scientistsprobe oxytocintherapyforsocial deficitsinautism, schizophrenia.Journal of
the AmericanMedical Association.2011,305:659-61.
[8] Perkeybile,A.M.,Griffin,L.L., Bales,K.L. Natural variationinearlyparental care correlateswith
social behaviorsinadolescentprairievoles(Microtusochrogaster).FrontiersinBehavioral Neuroscience.
2013,7:21.
[9] Rubin,L.H., Carter,C. S., Drogos,L., Jamadar,R., Pournajafi-Nazarloo,H.,Sweeney,J.A.,etal.Sex-
specificassociationsbetweenperipheraloxytocinandemotionperceptioninschizophrenia.
SchizophreniaResearch.2011,130:266-70.
[10] Souza,R. P.,Ismail,P.,Meltzer,H.Y., Kennedy,J.L.Variantsinthe oxytocingene andriskfor
schizophrenia.SchizophreniaResearch.2010,121:279-80.
[11] Goldman,M., Marlow-O'Connor,M.,Torres,I.,Carter, C.S. Diminishedplasmaoxytocinin
schizophreniapatientswithneuroendocrine dysfunctionandemotional deficits.Schizophrenia
Research.2008,98:247-55.
[12] Carter,C. S. Sex differencesinoxytocinandvasopressin:Implicationsforautismspectrum
disorders?Behavioral BrainResearch.2007,176:170-86.
[13] Gurrieri,F.,Neri,G.Defective oxytocinfunction:aclue to understandingthe cause of autism?BMC
Medicine.2009,7:63.
[14] Gregory,S. G., Connelly,J.J.,Towers,A.J.,Johnson,J.,Biscocho,D.,Marcunas,C. A.,etal. Genomic
and epigeneticevidence foroxytocin receptordeficiencyinautism.BMCMedicine.2009,7:62.
[15] Green,L., Fein,D.,Modahl,C.,Feinstein,C.,Waterhouse,L.,Morris,M. Oxytocinandautistic
disorder:alterationsinpeptideforms.Biol Psychiatry.2001,50:609-13.

22. 22
[16] Rubin,L. H., Carter,C. S.,Drogos,L., Pournajafi-Nazarloo,H.,Sweeney,J.A.,Maki,P.M. Peripheral
oxytocinisassociatedwithreducedsymptomseverityinschizophrenia.SchizophreniaResearch.
2010,124:13-21.
[17] Macdonald,K., Feifel,D.Oxytocininschizophrenia:a review of evidenceforitstherapeuticeffects.
Acta Neuropsychiatrica.2012,24:130-46.
[18] Guastella,A.J.,Einfeld,S.L.,Gray,K. M., Rinehart,N.J.,Tonge,B. J.,Lambert,T. J.,etal. Intranasal
oxytocinimprovesemotionrecognitionforyouthwithautismspectrumdisorders.Biological Psychiatry.
2010,67:692-4.
[19] Andari,E.,Duhamel,J.R., Zalla,T.,Herbrecht,E.,Leboyer,M., Sirigu,A.Promotingsocial behavior
withoxytocininhigh-functioningautismspectrumdisorders.ProcNatl AcadSci U S A.2010,107:4389-
94.
[20] Pedersen,C.A.,Gibson,C.M., Rau,S. W., Salimi,K.,Smedley,K.L.,Casey,R.L., et al.Intranasal
oxytocinreducespsychoticsymptomsandimprovesTheoryof Mindand social perceptionin
schizophrenia.Schizophrenia Research.2011,132:50-3.
[21] Feifel,D.,Macdonald,K.,Nguyen,A.,Cobb,P.,Warlan,H.,Galangue,B.,etal. Adjunctive intranasal
oxytocinreducessymptomsinschizophreniapatients.Biological Psychiatry.2010,68:678-80.
[22] Feifel,D.,Macdonald,K.,Cobb,P.,Minassian,A.Adjunctive intranasal oxytocinimprovesverbal
memoryinpeople withschizophrenia.SchizophreniaResearch.2012,139:207-10.
[23] Anagnoustou,E.,Soorya,L.,Chaplin,W.,Bartz,J., Halpern,D.,Wasserman,S.,etal. Intranasal
oxytocinversusplacebointhe treatmentof adultswithautismspectrumdisorders:arandomized
controlledtrial.MolecularAutism.2012,3:16.
[24] Hollander,E.,Novotny,S.,Hanratty,M.,Yaffe,R., DeCaria,C.M., Aronowitz,B.R.,et al.Oxytocin
infusionreducesrepetitive behaviorsinadultswithautisticandAsperger'sdisorders.
Neuropsychopharmacology.2003,1:193-8.
[25] Hollander,E.,Bartz,J., Chaplin,W.,Phillips,A.,Sumner,J.,Soorya,L.,etal.Oxytocinincreases
retentionof social cognitioninautism.BiolPsychiatry.2007,61:498-503.
[26] Geyer,M. A., Krebs-Thomson,K.,Braff,D.L.,Swerdlow,N.R.Pharmacological studiesof prepulse
inhibitionmodelsof sensorimotorgatingdeficitsinschizophrenia:adecide inreview.
Psychopharmacology.2001,156:117-54.
[27] Parwani,A.,Duncan,E. J., Bartlett,E.,Madonick,S. H.,Efferen,T.R., Rajan,R., etal. Impaired
prepulse inhibitionof acousticstartle inschizophrenia.Biological Psychiatry.2000,47:662-9.
[28] Braff,D. L. Prepulse inhibitionof the startle reflex:awindow onthe braininschizophrenia.Current
Topicsin Behavioral Neuroscience.2010,4:349-71.
[29] Schall,U., Schon,A.,Zerbin,D.,Eggers,C.,Oades,R. D. Event-relatedpotentialsduringanauditory
discriminationwith prepulseinhibitioninpatientswithschizophrenia,obsessive-compulsive disorder
and healthysubjects.IntJNeurosci.1996,84:15-33.
[30] Kumari,V.,Soni,W.,Mathew,V.M., Sharma,T. Prepulse inhibitionof the startle response inmen
withschizophrenia:effectsof age of onsetof illness,symptoms,andmedication.Archivesof General
Psychiatry.2000,57:609-14.
[31] Perry,W., Minassian,A.,Lopez,B.,Maron, L.,Lincoln,A.Sensorimotorgatingdeficitsinadultswith
autism.Biological Psychiatry.2007,61:482-6.
[32] Gogos, A.,vandenBuuse,M., Rossell,S.Genderdifferencesinprepulseinhibition(PPI) inbipolar
disorder:menhave reducedPPI,womenhave increasedPPI.International Journal of
Neuropsychopharmacology.2009,12:1249-59.
[33] Perry,W., Minassian,A.,Feifel,D.,Braff,D.L. Sensorimotorgatingdeficitsinbipolardisorder
patientswithacute psychoticmania.Biological Psychiatry.2001,50:418-24.
[34] Hoenig,K.,Hochrein,A.,Quednow,B.B.,Maier,W.,Wagner,M. Impairedprepulseinhibitionof
acousticstartle inobsessive-compulsive disorder.Biological Psychiatry.2005,57:1153-8.

23. 23
[35] Feifel,D.,Minassian,A.,Perry,W.Prepulse inhibitionof startle inadultswithADHD.Biological
Psychiatry.2009,43:484-9.
[36] Ahmari,S.E., Risbrough,V.B.,Geyer,M. A., Simpson,H.B.Impairedsensorimotorgatingin
unmedicatedadultswithobsessive-compulsivedisorder.Neuropsychopharmacology.2012,37:1216-23.
[37] Castellanos,F.X.,Fine,E.J.,Kaysen,D.,Marsh,W. L.,Rapoport,J. L., Hallett,M.Sensorimotor
gatingin boywithTourette'ssyndrome andADHD:preliminaryresults.Biological Psychiatry.
1996,39:33-41.
[38] Feifel,D.,Reza,T.Oxytocinmodulatespsychotomimetic-induceddeficitsinsensorimotorgating.
Psychopharmacology.1999,141:93-8.
[39] Feifel,D.,Shilling,P.D.,Belcher,A.M.The effectsof oxytocinanditsanalog,carbetocin,ongenetic
deficitsinsensorimotorgating.EuropeanJournalof Neuropsychopharmacology.2012,22:374-8.
[40] Caldwell,H.K.,Stephens,S.L.,YoungIII,W. S. Oxytocinasa natural antipsychotic:astudyusing
oxytocinknockoutmice.MolecularPsychiatry.2009,14:190-6.
[41] Koh,H. Y., Kim,D., Lee,J.,Lee,S.,Shin,H. S.Deficitsinsocial behaviorandsensorimotorgatingin
mice lackingphospholipaseCbeta1.GenesBrainBehav.2008,7:120-8.
[42] Lijam,N.,Paylor,R.,McDonald, M. P.,Crawley,J.N.,Deng,C. X.,Herrup,K.,et al.Social interaction
and sensorimotorgatingabnormalitiesinmice lackingDvl1.Cell.1997,90:895-905.
[43] Cilia,J.,Reavill,C.,Hagan,J.J., Jones,D.N. Long-termevaluationof isolation-rearinginduced
prepulse inhibitiondeficitsinrats.Psychopharmacology(Berl).2001,156:327-37.
[44] Roncada, P.,Bortolato,M., Frau,R., Saba,P., Flore,G.,Soggiu,A.,etal.Gating deficitsinisolation-
rearedrats are correlatedwithalterationsinproteinexpressioninnucleusaccumbens.JNeurochem.
2009,108:611-20.
[45] Bakshi,V.P.,Swerdlow,N.R.,Braff,D.L., Geyer,M. A. Reversal of isolationrearing-induceddeficits
inprepulse inhibitionbySeroquel andolanzapine.Biol Psychiatry.1998,43:436-45.
[46] Geyer,M. A., Wilkinson,L.S.,Humby,T., Robbins,T.W. Isolationrearingof ratsproducesa deficit
inprepulse inhibitionof acousticstartle similartothatin schizophrenia.Biol Psychiatry.1993,34:361-72.
[47] Moller,M., Du Preez,J.L., Emsley,R.,Harvey,B.H. Isolationrearing-induceddeficitsin
sensorimotorgatingandsocial interactioninratsare relatedtocortico-striatal oxidativestress, and
reversedbysub-chronicclozapine administration.EurNeuropsychopharmacol.2011,21:471-83.
[48] Fitzgerald,M.L., Mackie,K.,Pickel,V.M. The impactof adolescentsocial isolationondopamine D2
and cannabinoidCB1receptorsinthe adultrat prefrontal cortex.Neuroscience.2013,235:40-50.
[49] Varty,G. B., Geyer,M. A. Effectsof isolationrearingonstartle reactivity,habituation,andprepulse
inhibitioninmale Lewis,Sprague-Dawley,andFischerF344 rats. BehavNeurosci.1998,112:1450-7.
[50] Ralph,R. J.,Caine,S.B. Dopamine D1 and D2 agonisteffectsonprepulse inhibitionandlocomotion:
comparisonof Sprague-DawleyratstoSwiss-Webster,129X1/SvJ,C57BL/6J, andDBA/2J mice.J
Pharmacol ExpTher. 2005,312:733-41.
[51] Zhang,J., Forkstam, C.,Engel,J.A.,Svensson,L.Role of dopamine inprepulseinhibitionof acoustic
startle.Psychopharmacology(Berl).2000,149:181-8.
[52] Caine,S.B., Geyer,M. A.,Swerdlow,N.R.Effectsof D3/D2 dopamine receptoragonistsand
antagonistsonprepulse inhibitionof acousticstartle inthe rat. Neuropsychopharmacology.
1995,12:139-45.
[53] Kovacs,G. L., Sarnyai,Z.,Barbarczi, E., Szabo,G., Telegdy,G.The role of oxytocin-dopamine
interactionsincocaine-inducedlocomotorhyperactivity.Neuropharmacology.1990,29:365-8.
[54] Sarnyai,Z.,Babarczy, E., Krivan,M.,Szabo,G., Kovacs,G. L.,Barth, T., etal. Selectiveattenuationof
cocaine-inducedstereotypedbehaviourbyoxytocin:putative role of basal forebraintargetsites.
Neuropeptides.1991,19:51-6.
[55] Feifel,D.,Reza,T.Oxytocinmodulatespsychotomimetic-induceddeficitsinsensorimotorgating.
Psychopharmacology(Berl).1999,141:93-8.

24. 24
[56] Melis,M. R., Argiolas,A.,Gessa,G.L. Apomorphine increasesplasmaoxytocinconcentrationin
male rats. Neurosci Lett.1989,98:351-5.
[57] Melis,M. R., Argiolas,A.,Stancampiano,R.,Gessa,G.L. Effectof apomorphine onoxytocin
concentrationsindifferentbrainareasandplasmaof male rats.Eur J Pharmacol.1990,182:101-7.
[58] Smeltzer,M.D., Curtis,J.T., Aragona,B. J.,Wang, Z. Dopamine,oxytocin,andvasopressinreceptor
bindinginthe medial prefrontal cortex of monogamousandpromiscuousvoles.Neurosci Lett.
2006,394:146-51.
[59] Baskerville,T.A.,Douglas,A.J.Dopamine andoxytocininteractionsunderlyingbehaviors:potential
contributionstobehavioral disorders.CNSNeurosciTher.2010,16:e92-123.
[60] Gingrich,B.,Liu, Y., Cascio,C.,Wang, Z.,Insel,T.R. Dopamine D2 receptorsinthe nucleus
accumbensare importantfor social attachmentinfemale prairievoles(Microtusochrogaster).Behav
Neurosci.2000,114:173-83.
[61] Hostetler,C.M., Harkey,S.L., Krzywosinski,T.B.,Aragona,B. J.,Bales,K.L. Neonatal exposure to
the D1 agonistSKF38393 inhibitspairbondinginthe adult prairie vole.BehavPharmacol.2011,22:703-
10.
[62] Aragona,B. J., Liu,Y., Curtis,J.T., Stephan,F.K.,Wang, Z. A critical role for nucleusaccumbens
dopamine inpartner-preference formationinmale prairie voles.JNeurosci.2003,23:3483-90.
[63] Hammock,E. A.,Young,L. J. Oxytocin,vasopressinandpairbonding:implicationsforautism.Philos
Trans R Soc Lond B Biol Sci.2006,361:2187-98.
[64] Aragona,B. J., Liu,Y., Yu,Y. J.,Curtis,J.T., Detwiler,J.M.,Insel,T.R., etal. Nucleusaccumbens
dopamine differentiallymediatesthe formationandmaintenance of monogamouspairbonds.Nat
Neurosci.2006,9:133-9.
[65] Young,K. A.,Liu,Y., Gobrogge,K. L.,Dietz,D. M., Wang, H., Kabbaj,M.,et al.Amphetamine alters
behaviorandmesocorticolimbicdopaminereceptorexpressioninthe monogamousfemaleprairie vole.
Brain Res.2011,1367:213-22.
[66] Born, J.,Lange,T., Kern,W.,McGregor, G. P.,Bickel,U.,Fehm, H. L. Sniffingneuropeptides:a
transnasal approachto the human brain.Nature Neuroscience.2002,5:514-6.
[67] Norman,G. J., Cacioppo,J.T.,Morris, J. S.,Malarkey,W. B., Berntson,G.G., Devries,A.C.Oxytocin
increasesautonomiccardiaccontrol:moderationbyloneliness.Biological psychology.2011,86:174-80.
[68] Churchland,P.S.,Winkielman,P.Modulatingsocial behaviorwithoxytocin:how doesitwork?
What doesitmean?Hormonesand Behavior.2012,61:392-9.
[69] Porges,S.W. The polyvagal theory:phylogeneticsubstratesof asocial nervoussystem.
International Journal of Psychophysiology.2001,42:123-46.
[70] Cushing,B.S., Carter,C. S.Peripheral pulsesof oxytocinincrease partnerpreferencesinfemale,but
not male,prairie voles.HormonesandBehavior.2000,37:49-56.
[71] Neumann,I.D.,Maloumby,R.,Beiderbeck,D.I.,Lukas,M., Landgraf,R. Increasedbrainandplasma
oxytocinafternasal andperipheral administrationinratsandmice.Psychoneuroendocrinology.2013.
[72] Bales,K.L., Perkeybile,A.M.,Conley,O.G.,Lee,M. H., Guoynes,C.D.,Downing,G.M., etal.
Chronicintranasal oxytocincauseslong-termimpairmentinpartnerpreference formationinmale
prairie voles.Biological Psychiatry.2013,74:180-8.
[73] Modi, M. E., Young,L. J. The oxytocinsystemindrugdiscoveryforautism:animal modelsandnovel
therapeuticstrategies.HormonesandBehavior.2012,61:340-50.
[74] Geyer,M. A., Swerdlow,N.R.Measurementof startle response,prepulseinhibition,and
habituation.CurrentProtocolsinNeuroscience.2001,8:1-15.
[75] MacDonald, E.,Dadds, M. R., Brennan,J.L., Williams,K.,Levy,F.,Cauchi,A.J.A review of safety,
side-effectsandsubjective reactionstointranasal oxytocininhumanresearch.
Psychoneuroendocrinology.2011,36:1114-26.
[76] Bankowski,K.,Manning,M.,Seto,J.,Haldar,J., Sawyer,W. H. Designandsynthesisof potentinvivo
antagonistsof oxytocin.InternationalJournal of Peptide andProteinResearch.1980:382-91.

25. 25
[77] Bales,K.L., Kim,A.J., Lewis-Reese,A.D.,Carter,C.S. Both oxytocinandvasopressinmayinfluence
alloparental behaviorinmale prairie voles.HormonesandBehavior.2004,45:354-61.
[78] Bales,K.L., Carter,C. S. Developmentalexposure tooxytocinfacilitatespartnerpreferencesinmale
prairie voles(Microtusochrogaster).BehavioralNeuroscience.2003,117:854-9.
[79] Bales,K.L., Carter,C. S. Sex differencesanddevelopmental effectsof oxytocinonaggressionand
social behaviorinprairie voles(Microtusochrogaster).HormonesandBehavior.2003,44:178-84.
[80] Bales,K.L., Plotsky,P.M., Young,L. J.,Lim, M. M., Grotte, N.D., Ferrer,E.,et al.Neonatal oxytocin
manipulationshave long-lasting,sexuallydimorphiceffectsonvasopressinreceptors.Neuroscience.
2007,144:38-45.
[81] Arletti,R.,Benelli,A.,Bertolini,A.Influence of OxytocinonFeeding-Behaviorinthe Rat.Peptides.
1989,10:89-93.
[82] Olson,B.R., Drutarosky,M. D., Stricker,E. M., Verbalis,J.G.Brainoxytocinreceptorantagonism
bluntsthe effectsof anorexigenictreatmentsinrats - evidence forcentral oxytocininhibitionof food
intake.Endocrinology.1991,129:785-91.
[83] Argiolas,A.Neuropeptidesandsexualbehavior.Neurosci.Biobehav.Rev.1999,23:1127-42.
[84] Lipinski,C.A.,Lombardo,F.,Dominy,B.W., Feeney,P.J.Experimental andcomputational
approachesto estimate solubilityandpermeabilityindrugdiscoveryanddevelopmentsettings.
AdvancedDrugDeliveryReviews.2001,46:3-26.
[85] Ermisch,A.,Ruhle,H.-J.,Landgraf,R.,Hess,J.Blood-brainbarrierandpeptides.Journal of Cerebral
BloodFlowandMetabolism.1985,5:350-7.
[86] Smith,A.L., Freeman,S.M., Voll,R.J.,Young,L. J., Goodman,M. M. Carbon-11 N-methyl alkylation
of L-368,899 and invivoPET imaginginvestigationsforneural oxytocinreceptors.Bioorganic&
Medicinal ChemistryLetters.2013,23:902-6.
[87] Boccia, M. L., Goursaud,A. P.,Bachevalier,J.,Anderson,K.D.,Pedersen,C.A.Peripherally
administerednon-peptideoxytocinantagonist,L368,999, accumulatesinlimbicbrainareas:A new
pharmacological tool forthe studyof social motivationinnon-humanprimates.Hormonesand
Behavior.2007,52:344-51.
[88] Smith,A.S., Agmo,A.,Birnie,A.K.,French,J.A.Manipulationof the oxytocinsystemalterssocial
behaviorandattractioninpair-bondingprimates, Callithrix penicillata.HormonesandBehavior.
2010,57:255-62.
[89] Thompson,K.L., Vincent,S.H.,Miller,R.R., Colletti,A.E.,Alvaro,R.F., Wallace,M.A., etal.
Pharmacokineticsanddispositionof the oxytocinreceptorantagonistL-368,899 inrats anddogs.Drug
MetabolismandDisposition:the Biological Fate of Chemicals.1997,25:1113-8.
[90] Lim,M. M., Murphy, A.Z., Young,L. J. Ventral striatopallidal oxytocinandvasopressinV1areceptors
inthe monogamousprairie vole(Microtusochrogaster).JCompNeurol.2004,468:555-70.
[91] Olazabal,D.E., Young,L. J. Speciesandindividual differencesinjuvenile female alloparental care
are associatedwithoxytocinreceptordensityinthe striatumandthe lateral septum.HormBehav.
2006,49:681-7.
[92] Ophir,A.G., Gessel,A.,Zheng,D.J.,Phelps,S.M. Oxytocinreceptordensityisassociatedwithmale
matingtactics andsocial monogamy.HormBehav.2012.
[93] Insel,T.R., Shapiro,L.E. Oxytocinreceptordistributionreflectssocialorganizationinmonogamous
and polygamousvoles.ProcNatl AcadSci U S A. 1992,89:5981-5.
[94] Blevins,J.E.,Schwartz,M. W., Baskin,D. G. Evidence thatparaventricularnucleusoxytocinneurons
linkhypothalamicleptinactiontocaudal brainstemnuclei controllingmeal size.AmJPhysiol Regul
IntegrCompPhysiol.2004,287:R87-96.
[95] Gimpl,G., Fahrenholz,F.The oxytocinreceptorsystem:structure,function,andregulation.Physiol
Rev.2001,81:629-83.
[96] Swerdlow,N.R.,Braff,D.L., Geyer,M. A. Animal modelsof deficientsensorimotorgating:what we
know,whatwe thinkwe know,andwhat we hope to know soon.BehavPharmacol.2000,11:185-204.

26. 26
[97] Schmajuk,N.A.,Larrauri, J.A. Neural networkmodel of prepulse inhibition.BehavNeurosci.
2005,119:1546-62.
[98] Qu, Y., Weber,M.A.,Swerdlow,N.R. The NucleusAccumbensRegulationof SensorimotorGatingin
Animal ModelsandNeuropsychiatricDisorders.2008.
[99] Grippo,A. J.,Trahanas,D. M., Zimmerman,R.R.,Porges,S.W., Carter,C. S. Oxytocinprotects
againstnegative behavioral andautonomicconsequencesof long-termsocial isolation.
Psychoneuroendocrinology.2009,34:1542-53.
[100] Grippo,A.J.,Pournajafi-Nazarloo,H.,Sanzenbacher,L.L., Trahanas,D. M., McNeal,N.,Clarke,D.
A.,et al.Peripheral oxytocinadministrationbuffersautonomic butnotbehavioral responsesto
environmental stressorsinisolatedprairie voles.Stress.2012,15:149-61.
[101] Quintana,D.S.,Kemp,A.H., Alvares,G.A.,Guastella,A.J.A role forautonomiccardiac control in
the effectsof oxytocinonsocial behaviorandpsychiatricillness.FrontiersinNeuroscience.2013,7:1-9.
[102] Ramirez-Moreno,D.F.,Sejnowski,T.J.A computational model forthe modulationof the prepulse
inhibitionof the acousticstartle reflex.Biol Cybern.2012,106:169-76.
[103] Liu,J. L.,Li, M., Dang, X.R., Wang, Z. H.,Rao, Z. R., Wu,S. X., etal. A NMDA receptorantagonist,
MK-801 impairsconsolidatingextinctionof auditoryconditionedfearresponsesinaPavlovianmodel.
PLoS One.2009,4:e7548.
[104] Hoffman,D.C., Donovan,H., Cassella,J.V.The effectsof haloperidolandclozapine onthe
disruptionof sensorimotorgatinginducedbythe noncompetitive glutamateantagonistMK-801.
Psychopharmacology(Berl).1993,111:339-44.
[105] Bortolato,M.,Aru, G. N.,Fa, M., Frau, R.,Orru, M., Salis,P.,etal. Activationof D1,but not D2
receptorspotentiatesdizocilpine-mediateddisruptionof prepulseinhibitionof the startle.
Neuropsychopharmacology.2005,30:561-74.
[106] Hikichi,H.,Nishino,M.,Fukushima,M.,Satow,A.,Maehara,S.,Kawamoto,H.,et al.
Pharmacological effectsof metabotropicglutamate receptorligandsonprepulse inhibitioninDBA/2J
mice.Eur J Pharmacol.2010,639:99-105.
[107] Zou,D., Huang,J.,Wu, X., Li,L. Metabotropicglutamate subtype 5receptorsmodulate fear-
conditioninginducedenhancementof prepulse inhibitioninrats.Neuropharmacology.2007,52:476-86.
[108] Qi,J.,Yang, J. Y., Wang,F., Zhao,Y. N.,Song,M., Wu,C. F. Effectsof oxytocinon
methamphetamine-inducedconditionedplace preference andthe possiblerole of glutamatergic
neurotransmissioninthe medialprefrontal cortex of mice inreinstatement.Neuropharmacology.
2009,56:856-65.
[109] Qi,J.,Han, W. Y., Yang, J.Y., Wang, L. H., Dong,Y. X.,Wang,F., etal. Oxytocinregulateschangesof
extracellularglutamate andGABA levelsinducedbymethamphetamineinthe mouse brain.AddictBiol.
2012,17:758-69.
[110] Lehmann,J.,Pryce,C.R., Feldon,J.Sex differencesinthe acousticstartle response andprepulse
inhibitioninWistarrats.BehavBrain Res.1999,104:113-7.
[111] Swerdlow,N.R.,Auerbach,P.,Monroe,S.M.,Hartston, H.,Geyer,M. A.,Braff,D. L. Men are more
inhibitedthanwomenbyweakprepulses.BiolPsychiatry.1993,34:253-60.
[112] Ison,J.R., Allen,P.D.Pre- butnot post-menopausal femaleCBA/CaJmice show lessprepulse
inhibitionthanmale mice of the same age.BehavBrainRes.2007,185:76-81.
[113] Koch,M. Sensorimotorgatingchangesacrossthe estrouscycle infemale rats.Physiol Behav.
1998,64:625-8.
[114] Plappert,C.F.,Rodenbucher,A.M.,Pilz,P.K.Effectsof sex andestrouscycle on modulationof the
acousticstartle response inmice.Physiol Behav.2005,84:585-94.
[115] Adams,A.L., Hudson,A.,Ryan,C. L., Doucette,T.A.Effectsof estrousstage and time of day on
prepulse inhibitioninfemalerats.JNeurosci Methods.2008,173:295-8.
[116] Braff,D. L., Geyer,M. A.,Swerdlow,N.R.Humanstudiesof prepulse inhibitionof startle:normal
subjects,patientgroups,andpharmacological studies.Psychopharmacology(Berl).2001,156:234-58.

27. 27
[117] Swerdlow,N.R.,Hartman,P.L., Auerbach,P.P.Changesinsensorimotorinhibitionacrossthe
menstrual cycle:implicationsforneuropsychiatricdisorders.BiolPsychiatry.1997,41:452-60.
[118] Abel,K.M., Drake,R., Goldstein,J.M.Sex differencesinschizophrenia.IntRevPsychiatry.
2010,22:417-28.
[119] Rubin,L.H., Carter,C. S., Drogos,L., Jamadar,R., Pournajafi-Nazarloo,H.,Sweeney,J.A.,etal.Sex-
specificassociationsbetweenperipheraloxytocinandemotionperceptioninschizophrenia.Schizophr
Res.2011,130:266-70.
[120] Rubin,L.H., Carter,C. S., Drogos,L., Pournajafi-Nazarloo,H.,Sweeney,J.A.,Maki,P.M. Peripheral
oxytocinisassociatedwithreducedsymptomseverityinschizophrenia.SchizophrRes.2010,124:13-21.
[121] Peter,J.,Burbach,H.,Adan,R. A., Tol,H. H., Verbeeck,M.A.,Axelson,J.F.,etal.Regulationof the
rat oxytocingene byestradiol.JNeuroendocrinol.1990,2:633-9.
[122] Stedronsky,K.,Telgmann,R.,Tillmann,G.,Walther,N.,Ivell,R.The affinityandactivityof the
multiple hormoneresponse elementinthe proximal promoterof the humanoxytocingene.J
Neuroendocrinol.2002,14:472-85.
[123] Feifel,D.,Shilling,P.D.,Belcher,A.M. The effectsof oxytocinanditsanalog,carbetocin,on
geneticdeficitsinsensorimotorgating.EurNeuropsychopharmacol.2011.
[124] Bales,K.L., Perkeybile,A.M.,Conley,O.G.,Lee,M. H., Guoynes,C.D., Downing,G.M., et al.
ChronicIntranasal OxytocinCausesLong-TermImpairmentsinPartnerPreferenceFormationinMale
Prairie Voles.BiolPsychiatry.2012.
[125] Grippo,A.J.,Pournajafi-Nazarloo,H.,Sanzenbacher,L.,Trahanas,D. M., McNeal,N.,Clarke,D. A.,
et al.Peripheral oxytocinadministrationbuffersautonomicbutnotbehavioral responsesto
environmental stressorsinisolatedprairie voles.Stress.2012,15:149-61.
[126] Cushing,B.S.,Carter,C. S. Peripheral pulsesof oxytocinincreasepartnerpreferencesinfemale,
but notmale,prairie voles.HormBehav. 2000,37:49-56.
[127] Varty,G. B., Walters,N.,Cohen-Williams,M.,Carey,G.J. Comparisonof apomorphine,
amphetamine anddizocilpine disruptionsof prepulseinhibitionininbredandoutbredmice strains.EurJ
Pharmacol.2001,424:27-36.
[128] Swerdlow, N.R.,Shoemaker,J.M.,Crain,S.,Goins,J., Onozuka,K.,Auerbach,P.P.Sensitivityto
drug effectsonprepulse inhibitionininbredandoutbredratstrains.Pharmacol BiochemBehav.
2004,77:291-302.
[129] Flood,D.G., Zuvich,E.,Marino, M. J., Gasior,M. Prepulse inhibitionof the startle reflex and
response toantipsychotictreatmentsintwooutbredmouse strainsincomparisontothe inbredDBA/2
mouse.Psychopharmacology(Berl).2011,215:441-54.
[130] Guastella,A.J.,Hickie,I.B.,Mcguinness, M.M., Otis,M., Woods,E. A., Disinger,H.M.,et al.
Recommendationsforthe standardisationof oxytocinnasal administrationandguidelinesforits
reportinginhumanresearch.Psychoneuroendocrinology.2013,38:612-25.

28. 28
Figure Legends.
Figure 1. Study design. Subjects were sorted into two groups based on a initial pre-test.
Animals displaying 60% or greater PPI were put into the OTA experiment (left half of figure),
while animals displaying poor inhibition (less than 60% PPI) were put into the OT experiment
(right half of figure). Average %PPI for the voles put into the intranasal OT experiment was
16.08 + 9.85% at the 90dB prepulse level, while average %PPI for voles put into the OTA
experiment was 67.63 + 1.97% at the 90dB prepulse level. Each animal received two treatments
(saline and OT; saline and COTA; or saline and POTA) in a counter-balanced fashion.
Figure 2. Baseline startle in the intranasal OT study. Startle amplitude in pulse only trials in the
OT study showed a trend for animals given OT to display lower startle amplitude (F1, 21 = 3.87, p
= 0.062). The top panel shows means and standard errors by group. Because individual
differences in a repeated measures design can be swamped in a standard graph of means +
standard errors, the bottom panel indicates the means + standard errors of the difference for each
individual between saline and OT treatment (thus a positive difference means startle amplitude
was higher when given saline).
Figure 3. Baseline startle in the OTA study. Startle amplitude in pulse only trials in the OTA
study showed a significant effect of treatment (F1, 36 = 3.75, p = 0.033) and a moderately
significant sex by treatment interaction (F2,36 = 3.23, p = 0.051). Post-hoc tests in males showed
significant differences between saline and COTA (t1 = 2.605, p = 0.013) and between saline and
POTA (t1 = 2.177, p = 0.036). Because individual differences in a repeated measures design can
be swamped in a standard graph of means + standard errors, the bottom panel indicates the

29. 29
means + standard errors of the difference for each individual between saline and OTA treatment
(thus a positive difference means startle amplitude was higher when given saline). Significant
differences are marked by asterisks.
Figure 4. %PPI in the intranasal OT study. In 78 dB trials of intranasal OT treatment there was a
significant effect of treatment, such that intranasal OT administration significantly worsened PPI
in both sexes (F1,20 = 5.81, P = 0.026). Because individual differences in a repeated measures
design can be swamped in a standard graph of means + standard errors, the bottom panel
indicates the means + standard errors of the difference for each individual between saline and OT
treatment (thus a positive difference means %PPI was higher when given saline). Significant
differences are marked by asterisks.
Figure 5. % PPI in the OTA study (males). In 90 dB trials of OTA administration, there was a
significant effect of treatment (F2,35= 3.31, P = 0.048), with OTA treatment worsening PPI. Post-
hoc tests (least-squares means) indicated that for males, COTA significantly worsened PPI as
compared to saline treatment (t = 2.57, p = 0.015), while POTA did not (t = 0.14, P = 0.892).
Because individual differences in a repeated measures design can be swamped in a standard
graph of means + standard errors, the bottom panel indicates the means + standard errors of the
difference for each individual between saline and OTA treatment (thus a positive difference
means %PPI was higher when given saline). Significant differences are marked by asterisks.

30. 30
Figure 6. % PPI in the OTA study (females). For females, POTA worsened PPI as compared to
saline (t = 2.11, P = 0.042), while COTA did not (t = .295, P = 0.770). Because individual
differences in a repeated measures design can be swamped in a standard graph of means +
standard errors, the bottom panel indicates the means + standard errors of the difference for each
individual between saline and OTA treatment (thus a positive difference means %PPI was higher
when given saline). Significant differences are marked by asterisks.